Eureca-V™ Nuclease: the wild-type MAD7® CRISPR Type-V nuclease licensed from Inscripta®

The Eureca-VTM Nuclease (MAD7®) is a novel Type-V CRISPR nuclease that is particularly well suited to allogeneic cell therapy applications. Here, we chart the development of this important recent addition to the gene editing arsenal.

Please enter your email to access content Read now